Latest Updates
-
Women Car Rally Held In Gurugram On International Women’s Day, Boldsky Collaborates As Media Partner -
The Protein Gap In Women’s Diets: Gynaecologist Explains Why This Nutrient Matters From Puberty To Menopause -
Ralph Lauren Showcases ‘Jhumkas’ At Paris Fashion Week, Rekindling Debate On Credit For Indian Craft -
Viral Video: Pakistani Family Celebrates India’s T20 World Cup Victory With Cake, Sings Indian National Anthem -
Who Is Aditi Hundia? Viral Video Shows Ishan Kishan Celebrating India’s T20 World Cup Win With Girlfriend -
India Seal Historic T20 World Cup Win: Samson Tournament Star, Bumrah Match Hero, Dhoni Posts Special Message -
Horoscope for Today March 09, 2026 - Small Steps, Big Progress -
International Women’s Day 2026: 7 Powerful Ayurvedic Foods Every Woman Should Start Adding To Her Daily Diet -
What If WiFi, GPS Or Dishwashers Didn’t Exist? This Instagram Reel Credits Women Behind Everyday Inventions -
Women’s Day 2026: Why Creating Relaxation Spaces At Home Matters For Women Balancing Multiple Roles
Gene Therapy For Blindness Improves Vision
Researchers from University of Florida and University of Pennsylvania have successfully able to restore vision among patients with a rare form of congenital blindness using gene therapy, thus showing that the treatment is fully safe.
In Leber Congenital Amaurosis type 2 disease, photoreceptor cells cannot respond to light because a gene called RPE65 does not properly produce a protein necessary for healthy vision.
Researchers used an adeno-associated virus — an apparently harmless virus that already exists in most people to deliver RPE65 to a small area of the retina. The results showed that not only were there no ill effects other than routine post surgical soreness, the vision in the subjects" treated eyes was slightly improved in dim lighting conditions.
"The patients report seeing brighter areas and perhaps some images, but basically the message is that this is treatment is fully safe," said William W. Hauswirth, Ph.D., a professor of ophthalmology and member of UF's Powell Gene Therapy Centre and the UF Genetics Institute.
"One thing we did not do is suppress the patients' immune systems, which was done in two other LCA clinical trials that were under way," said Hauswirth, who began studying the adeno-associated virus as a vehicle to deliver genes into living animals more than 30 years ago.
"Theoretically, the idea was that it might be necessary to suppress the immune system because we are using a vector that might activate the body's defenses and cause a harmful response.
"However, immune suppression itself carries a risk of infections and other problems. Clearly we have shown there is no need to do that in this case," he added.
"The study has partially restored vision in three young adults, and it demonstrates that gene therapy can be effective in treating human vision disease," said Paul A. Sieving, M.D., Ph.D., director, National Eye Institute of the National Institutes of Health. The paper is published online today in Human Gene Therapy.
Disclaimer: The information provided in this article is for general informational and educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or a qualified healthcare provider with any questions you may have regarding a medical condition.



Click it and Unblock the Notifications











